Long-Term Intervention with Beta-Blocking Agents in Ischemic Heart Disease

  • Lars Wilhelmsen
Part of the Ettore Majorana International Science Series book series (EMISS, volume 4)


Coronary heart disease (CHD) is the predominant cause of death in most industrialized countries. Sudden coronary death (SD) occuring within one hour, or, according to other definitions, within 24 hours of the onset of symptoms, has been found to be the most common type of death, both in the early phases of CHD and during several years’ follow-up after a myocardial infarction (MI) (1, 2). There is reason to believe that most of these sudden deaths are due to ventricular tachyarrhythmias. In an attempt to find a basis for secondary preventive measures against CHD, it might be useful to study both risk factors both for a first and a secondary CHD event, and possible pathophysiologic mechanisms for the sudden cardiovascular catastrophe (3).


Coronary Heart Disease Infarct Size Sudden Death Ventricular Fibrillation Threshold Coronary Drug Project 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    M. Rono, Factors related to sudden death in acute ischemic heart disease. Acta Med Scand (Suppl) 547:194 (1972).Google Scholar
  2. 2.
    B. Lown, “Sudden death from coronary heart disease. Early Phases of Coronary Heart Disease: The Possibility of Prediction”. Skandia International Symposia, Stockhold, (1973) pp 255–277.Google Scholar
  3. 3.
    L. Wilhelmsen, A. Vedin, C. Wilhelmsson: Beta blockade and sudden death following myocardial infarction. Cardiovasc. Med. 3:557–563 (1978).Google Scholar
  4. 4.
    F. H. Epstein: Risk factors in coronary heart disease: environmental and hereditary influences. Isr. J. Med Sci 3:594–607 (1967).PubMedGoogle Scholar
  5. 5.
    Report of Inter-Society Commission for Heart Disease Resources: Primary prevention of the atherosclerotic diseases. Circulation 42:A55–95 (1970).Google Scholar
  6. 6.
    H. Blackburn, H. L. Taylor, A. Keys: Coronary heart disease in seven countries: the electrocardiogram as predictor of five-year coronary heart disease incidence among men aged forty through fifty-nine. Circulation 41–42 (suppl 1) 154 (1970).Google Scholar
  7. 7.
    A. Vedin, C. Wilhelmsson, D. Elmfeldt, G. Tibblin, L. Wilhelmsen, L. Werkö: Sudden death: identification of high risk groups. Am Heart J. 86:124–132 (1973).PubMedCrossRefGoogle Scholar
  8. 8.
    B. Kannel, T. Gordon: “Assessment of coronary vulnerability. Early Phases of Coronary Heart Diseases: The Possiblity of Prediction”. Skandia International Symposia, Stockholm (1973) p.123.Google Scholar
  9. 9.
    L. Wilhelmsen, H. Wedel, G. Tibblin: Multivariate analysis of risk factors for coronary heart disease. Circulation 48:950–958 (1973).PubMedGoogle Scholar
  10. 10.
    D. Elmfeldt, A. Vedin, C. Wilhelmsson, Tibblin, L. Wilhelmsen, Morbidity in representative male survivors of myocardial infarction compared to representative pupulation samples. J. Chronic Dis. 29:221–231 (1976).PubMedCrossRefGoogle Scholar
  11. 11.
    G. Tibblin, L. Wilhelmsen, L. Werkö: Risk factors for myocardial infarction and death due to ischemic heart disease and other causes. Am J Cardiol. 35:514–522 (1975).PubMedCrossRefGoogle Scholar
  12. 12.
    B. W. Chiang, L. V. Perman, L. Ostrander, F. Epstein: Relationship of premature systoles to coronary heart disease and sudden death in the Tecumseh epidemiologic study. Ann Intern Med. 70:1159–1166 (1969).PubMedGoogle Scholar
  13. 13.
    A. Vedin, C. Wilhelmsson, L. Wilhelmsen, B. Ekström-Jodal, J. Bjure: The relationships of resting and exercise induced ectopic beats to other ischemic manifestations and to coronary risk factors. Am J Cardiol. 30:25–31 (1972).PubMedCrossRefGoogle Scholar
  14. 14.
    L. Wilhelmsen, G. Tibblin, M. Aurell, J. Bjure, B. Ekström-Jodal, G. Grimby,: Physical activity, physical fitness and risk of myocardial infarction. Adv. Cardiol. 18:217–230 (1976).PubMedGoogle Scholar
  15. 15.
    A. J. Moss, J. De Camilla, F. Engström, W. Hoffman, C. Odoroff, H. Davis,: The posthospital phase of myocardial infarction: identification of patients with increased mortality risk. Circulation 49:460–466 (1974).PubMedGoogle Scholar
  16. 16.
    Coronary Drug Project Research Group: Prognostic importance of premature beats following myocardial infarction: Experience in the coronary drug project. JAMA 223:1116–1124 (1973).CrossRefGoogle Scholar
  17. 17.
    M. N. Kotier, B. Tabatznik, M. M. Mower, S. Tominage: Prognostic significance of ventricular ectopic beats with respect to sudden death in the late postinfarction period. Circulation 47:959–966 (1973).Google Scholar
  18. 18.
    L. A. Vismara, E. A. Amsterdam, D. T. Mason,: Relation of ventricular arrhythmias in the late hospital phase of acute myocardial infarction to sudden death after hospital discharge. Am. J. Med. 59:6–12 (1975)PubMedCrossRefGoogle Scholar
  19. 19.
    N. E. Shunway, J. A. Johnson, R. J. Stish: The study of ventricular fibrillation by threshold determinations. J. Thorac Surg. 34:643 (1957).Google Scholar
  20. 20.
    C. M. Phibbs, R. A. van Tyn, L. D. McLean: Vulnerability of the dog heart to ventricular fibrillation: A comparative study of chronic ischemia and three myocardial revascularization procedures. J. Thorac Cardiovasc. Surg. 42:228–235 (1961).PubMedGoogle Scholar
  21. 21.
    B. Lown, M. Wolf: Approaches to sudden death from coronary heart disease. Circulation 44:130 (1971).PubMedGoogle Scholar
  22. 22.
    S. Sakaibara, H. Hiratsuka, Y. Ota, H. Gomi, M. Yokoyama, T. Akimoto, K. Kishi: An elevation of ventricular fibrillation threshold after surgical resection of infarcted myocardium. Am. Heart J. 74:381–386 (1967).CrossRefGoogle Scholar
  23. 23.
    D. L. Page, J. B. Caulfield, J. A. Kastor, R. W. DeSanctis,: Myocardial changes associated with cardiogenic shock. N. Engl. J. Med. 285:133–137 (1971).PubMedCrossRefGoogle Scholar
  24. 24.
    E. Braunwald, P. R. Maroko: The reduction of infarct size — an idea whose time (for testing) has come. Circulation 50:206–209 (1974).PubMedGoogle Scholar
  25. 25.
    C. Wilhelmsson, A. Vedin, L. Wilhelmsen, G. Tibblin: Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Lancet 2:1157–1159 (1974).PubMedCrossRefGoogle Scholar
  26. 26.
    R. Roberts, A. Husain, H. D. Ambos, G. C. Oliver, J. R. Cox Jr. B. E. Sobel: Relation between infarct size and ventricular arrhythmia. Br. Heart J. 37:1169–1175 (1975).PubMedCrossRefGoogle Scholar
  27. 27.
    P. R. Maroko, P. Libby, J. W. Covell, B. E. Sobel, J. Ross Jr., E. Braunwald: Precordial ST segment elevation mapping: an atraumatic method for assessing alterations in the extent of myocardial interventions. Am J. Cardiol. 29:223–230 (1972).PubMedCrossRefGoogle Scholar
  28. 28.
    J. Pelides, D. W. Reid, M. Thomas, J. P. Shillingford: Inhibition by beta-blockade of the ST segment elevation after acute myocardial infarction in man. Cardiovasc Res. 6:295–301 (1972).PubMedCrossRefGoogle Scholar
  29. 29.
    R. C. Leinback. H. K. Cold, M. J. Buckley, G. W. Austen, C. A. Saunders: Reduction of myocardial injury during acute myocardial infarction by early application of intra-aortic balloon pumping and propranolol (abstract). Circulation 48 (suppl.4): 100 (1973).Google Scholar
  30. 30.
    B. I. Pentecost, G. W. Austen: Beta-adrenergic blockade in experimental myocardial infarction. Am. Heart J. 72:790 (1966).PubMedCrossRefGoogle Scholar
  31. 31.
    M. I. Khan, J. T. Hamilton, G. W. Manning,: Protective effect of beta adrenoceptor blockade in experimental coronary occlusion in conscious dogs. Am J. Cardiol, 30:832–837 (1972).PubMedCrossRefGoogle Scholar
  32. 32.
    G. J. Kelliher, C. Widmer, J. Roberts: Seventh annual meeting of the international study group for research in cardiac metabolism. Abstract No.141, Quebec (1974).Google Scholar
  33. 33.
    A. Vedin, L. Wilhelmsen. H. Wedel, B. Pettersson, C. Wilhelmsson, D. Elmfeldt, G. Tibblin: Prediction of cardiovascular deaths and nonfatal reinfarctions after myocardial infarction. Acta Med Scand. 201:309–316 (1977).PubMedCrossRefGoogle Scholar
  34. 34.
    E. A. Amsterdam, S. Wolfson, R. Gorlin: Effect of therapy on survival in angina pectoris. Ann Intern Med. 68:1151 (1968).Google Scholar
  35. 35.
    J. A. Vedin, C. Wilhelmsson, G. Tibblin, L. Wilhelmsen. L. Werkö: Chronic alprenolol treatment of patients with acute myocardial infarction after discharge from hospital. Acta Med Scand (Suppl) 575:9–24 (1975).Google Scholar
  36. 36.
    G. Ahlmark, H. Saetre, M. Korsgren: Reduction of sudden deaths after myocardial infarction. Lancet 2:1563 (1974).PubMedCrossRefGoogle Scholar
  37. 37.
    G. Ahlmark. H. Saetre,: Long-term treatment with betablockers after myocardial infarction. Eur J Clin Pharmacol. 10:77–83 (1976).PubMedCrossRefGoogle Scholar
  38. 38.
    K. G. Green,: Improvement in prognosis of myocardial infarction by long-term beta-adrenoreceptor blockade using practolol. Br Med J., 3:735–740 (1975).CrossRefGoogle Scholar
  39. 39.
    R. G. Diaz, J. Somberg, E. Freeman, B. Levitt: Withdrawal of propranolol and myocardial infarction. Lancet 1:1068, (1973).PubMedCrossRefGoogle Scholar
  40. 40.
    R. Slome: Withdrawal of propranolol and myocardial infarction. Lancet 1:156 (1973).PubMedCrossRefGoogle Scholar
  41. 41.
    E. L. Alderman, J. Coltart, G. E. Wettack, et al: Coronary artery syndromes after sudden propranolol withdrawal. Ann Intern Med., 81:625–627 (1974).PubMedGoogle Scholar
  42. 42.
    R. R. Miller, H. G. Olsson, E. A. Amsterdam, et al: Propranolol withdrawal rebound phenomenon. N. Eng. J. Med., 293:416–418 (1975).CrossRefGoogle Scholar
  43. 43.
    B.D. Kosowsky, J. Taylor, B. Lown, R. F. Ritchie,: Long-term use of procaine amide following acute myocardial infarction Circulation 47:1204–1210 (1973)PubMedGoogle Scholar
  44. 44.
    D. T. Jones, W. J. Kostuk, R. W. Gunton: Prophylactic quinidine for the prevention of arrhythmias after acute myocardial infarction. Am J Card., 33:655–660 (1974).PubMedCrossRefGoogle Scholar
  45. 45.
    R. R. H. Lowell, et al: Phenytoin after recovery from myocardial infarction. Lancet 2:1055–1057 (1971).Google Scholar
  46. 46.
    C. Wilhelmsson, J. A. Vedin, D. Elmfeldt, G. Tibblin, L. Wilehlmsen: Smoking and myocardial infarction. Lancet 1:415–420 (1975).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1980

Authors and Affiliations

  • Lars Wilhelmsen
    • 1
  1. 1.Department of MedicineÖstra HospitalGöteborgSweden

Personalised recommendations